JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 16, 2008, 10.2967/jnumed.108.051805
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.051805v1
49/8/1353    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cai, Z.
Right arrow Articles by Vallis, K. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cai, Z.
Right arrow Articles by Vallis, K. A.
Journal of Nuclear Medicine Vol. 49 No. 8 1353-1361
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.108.051805

Basic Science Investigation

Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF

Zhongli Cai1, Zhuo Chen2, Kristy E. Bailey2, Deborah A. Scollard3, Raymond M. Reilly1,3,4 and Katherine A. Vallis5

1 Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; 2 Division of Applied Molecular Oncology, Ontario Cancer Institute, Toronto, Ontario, Canada; 3 Division of Nuclear Medicine, Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; 4 Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada; and 5 Radiation Oncology and Biology, University of Oxford, Oxford, United Kingdom

Correspondence: For correspondence or reprints contact: Katherine A. Vallis, Radiobiology Research Institute, Churchill Hospital, Oxford, OX3 7LJ, U.K. E-mail: katherine.vallis{at}rob.ox.ac.uk

The Auger electron–emitting radiopharmaceutical 111In-diethylenetriaminepentaacetic acid human epidermal growth factor (111In-DTPA-hEGF) binds the epidermal growth factor receptor (EGFR), is internalized, and translocates to the nucleus. The purpose of this study was to investigate the relationship between EGFR expression, DNA damage, and cytotoxicity in cells exposed to 111In-DTPA-hEGF. Methods: Breast cancer cell lines with a range of EGFR expression levels were exposed to 111In-DTPA-hEGF or {gamma}-radiation. The cell lines (followed by number of EGFR per cell in parentheses) were MDA-MB-468 (1.3 x 106), MDA-MB-231 (1.3 x 105), and MCF-7 (1.5 x 104). The proportion of radioactivity partitioning into the nucleus was measured by cell fractionation. DNA double-strand breaks were evaluated using the {gamma}-H2AX assay. Clonogenic survival assays were used to measure cytotoxicity. Results: All data are presented as mean ± SD. The amount of 111In-DTPA-hEGF that translocated to the nucleus (in mBq/nucleus) in MDA-MB-468, MDA-MB-231, and MCF-7 cells incubated with 111In-DTPA-hEGF (5.2 MBq/mL, 43 nM) for 20 h was 131 ± 6, 8.1 ± 0.1, and 1.1 ± 0.9, respectively. The number of {gamma}-H2AX foci per nucleus was 35 ± 15, 19 ± 10, and 1.7 ± 0.3, respectively. A reduction in the surviving fraction (SF) in MDA-MB-468 (0.013 ± 0.001) and MDA-MB-231 (0.5 ± 0.1) but not in MCF-7 cells after exposure to 111In-DTPA-hEGF (5.2 MBq/mL, 43 nM) for 20 h has been demonstrated. The SF of MDA-MB-468 cells after exposure to DTPA-EGF (43 nM) and 111In-acetate (5.2 MBq/mL) for 20 h was 0.5 ± 0.1 and 0.53 ± 0.05, respectively. MDA-MB-468 was the most sensitive of the cell lines to {gamma}-irradiation, with an SF after 2 Gy of 0.45 ± 0.04, compared with 0.7 ± 0.1 and 0.8 ± 0.1 for MCF-7 and MDA-MB-231, respectively. The number of {gamma}-H2AX foci per nucleus in MDA-MB-468 cells correlated with the concentration, specific activity, and incubation time of 111In-DTPA-hEGF. Conclusion: DNA damage caused by 111In-DTPA-hEGF correlates with the EGFR expression level of the exposed cells and with concentration, specific activity, and incubation time of 111In-DTPA-hEGF. The {gamma}-H2AX assay may be a useful biomarker to predict and monitor the outcome of treatment with 111In-DTPA-hEGF.

Key Words: Auger electrons • H2AX • 111In-DTPA-hEGF • epidermal growth factor receptor

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.